What it is
Buprenorphine is an opioid used to treat opioid addiction. It is usually combined with naloxone (Suboxone) as a film or tablet under the tongue, or given as a monthly injection. A low-dose patch is also used for pain. It reduces cravings and withdrawal so people can stop using heroin, fentanyl or pain pills.
How it works
Buprenorphine partly activates opioid receptors. Its effects level off at higher doses, a “ceiling” that makes overdose much less likely than with full opioids. It still causes sedation and can be dangerous with alcohol or benzodiazepines. Some prescribed buprenorphine is diverted and sold.
How it is used
- Sold or traded from prescriptions
- Used without a prescription to manage withdrawal
- Taken with sedatives or alcohol
- Injected rather than taken under the tongue
Effects and warning signs
- Drowsiness, constipation, headache
- Pinpoint pupils at higher doses
- Withdrawal if stopped suddenly
- Overdose risk rises with sedatives
Why it matters at work
- Most users are in recovery
- Can cause drowsiness early in treatment
- Protected medical treatment; MRO review essential
The Labb BUP test
A BUP result is a Non-Negative screen until a laboratory confirms it. Most confirmed positives trace to a prescription the MRO will verify. In treatment, a negative BUP can mean a patient is not taking their medicine, or is diverting it. Lab testing can show whether the urine contains the body's breakdown product.
| Kit | Specimen | Cutoff (ng/mL) |
|---|---|---|
| eTest Swab OR:12A | Oral fluid | 5 |
| eTest Swab OR:14A | Oral fluid | 5 |
| eTest Cup UA:13A SVT | Urine | 10 |
| eTest Cup UA:15A | Urine | 10 |
| eTest Cup UA:18C SVT | Urine | 10 |
| eTest Cup UA:23A SVT | Urine | 10 |
This profile is educational and does not replace a package insert, laboratory guidance or medical advice. A rapid test result is a Non-Negative screen until a laboratory confirms it.
